Krognes Steve E.

Pliant Therapeutics, Inc. · Director

Krognes Steve E. is listed in public filings as director. This Krognes Steve E. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Pliant Therapeutics, Inc. (PLRX), Guardant Health Inc (GH), and Denali Therapeutics Inc. (DNLI). Investors use Krognes Steve E.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Guardant Health IncGH$1.4M10.2k sharesSellJun 4, 2026$1.2M9.3k shares$132.51--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Pliant Therapeutics, Inc.PLRX$699k53.5k sharesGrant / ExerciseJun 13, 2024$699.1K53.5k shares$13.06--
Pliant Therapeutics, Inc.PLRX$48k30k sharesGrant / ExerciseJun 5, 2025$48.3K30k shares$1.61--
Guardant Health IncGH--772 sharesGrant / ExerciseJan 31, 2026Disclosure amount unavailable154 shares----
Guardant Health IncGH--618 sharesGrant / ExerciseFeb 28, 2026Disclosure amount unavailable154 shares----
Guardant Health IncGH--463 sharesGrant / ExerciseMar 31, 2026Disclosure amount unavailable155 shares----
Guardant Health IncGH--309 sharesGrant / ExerciseApr 30, 2026Disclosure amount unavailable154 shares----
Guardant Health IncGH--155 sharesGrant / ExerciseMay 31, 2026Disclosure amount unavailable154 shares----
Denali Therapeutics Inc.DNLI$784k34.4k sharesSellJul 1, 2024$2.3K100 shares$22.80--
Denali Therapeutics Inc.DNLI$763k34.5k sharesSellJul 1, 2024$661.4K29.9k shares$22.12--
Denali Therapeutics Inc.DNLI$1.1M52.6k sharesSellJun 13, 2024$15.0K688 shares$21.79--
Denali Therapeutics Inc.DNLI$777k32.7k sharesSellAug 20, 2024$41.1K1.7k shares$23.79--
Denali Therapeutics Inc.DNLI$845k29.1k sharesSellSep 30, 2024$870.9K30k shares$29.03--
Denali Therapeutics Inc.DNLI$589k29.1k sharesSellDec 31, 2024$607.5K30k shares$20.25--
Denali Therapeutics Inc.DNLI$536k25.8k sharesSellJan 7, 2025$69.5K3.3k shares$20.81--
Denali Therapeutics Inc.DNLI$252k18.1k sharesGrant / ExerciseJun 3, 2025$252.3K18.1k shares$13.93--
Denali Therapeutics Inc.DNLI--31.8k sharesGrant / ExerciseJun 3, 2025Disclosure amount unavailable6k shares----
Denali Therapeutics Inc.DNLI$378k19.2k sharesGrant / ExerciseJun 3, 2026$378.0K19.2k shares$19.66--
Denali Therapeutics Inc.DNLI--38.2k sharesGrant / ExerciseJun 3, 2026Disclosure amount unavailable6.4k shares----